The proportion of CD8+ T-cells was significantly increased in the tumours, but not in the peripheral blood, cervical lymph nodes, peripheral lymph nodes, and spleen of PAK4 inhibitor-treated mice compared with that in the respective tissue of control mice (Fig. 5a). Here, PAK4 is linked to neoplasm.